Sodium Nitroprusside Injection, Solution, Concentrate
Product Images NDC 67457-839

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Sodium Nitroprusside (NDC 67457-839). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sodium Nitroprusside Structural Formula (Image 01)

Chemical structure of sodium nitroprusside, showing a central iron (Fe) atom coordinated with cyanide (CN) groups, a nitrosyl group (ON), and sodium ions (Na+), along with two water molecules (2 H2O).*

FDA Label Image

Sodium Nitroprusside Metabolism (Image 02)

Diagram illustrating the metabolism of Sodium Nitroprusside, showing its interaction with active cytochromes, conversion to cyanide, cyanmethemoglobin, methemoglobin, thiosulfate, and their renal excretion pathways.*

FDA Label Image

Sodium Nitroprusside Injection, Usp 50 mg/2 mL Carton Label (Image 03)

Sodium Nitroprusside Injection 50 mg/2 mL (25 mg/mL) single-dose vial carton packaging label. It is an intravenous infusion injection solution concentrate, manufactured by Mylan Institutional LLC. The label includes dilution instructions, storage conditions, and a warning to protect from light. The package contains a 2 mL vial with a blue stripe and the Mylan logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.